Price controls will slow drug innovation
Navigating the regulatory regimen is “hugely expensive,” said Ian Adams, Sacramento director of the R Street Institute, a right-of-center think tank. This is “some of the most sophisticated science going on in the world” and researchers don’t know if any investment will pay off.
Featured Publications
Toward Clarity and Consensus on “E”SG
ITC Policy Project Series: Record-Breaking Year at the ITC (for NPEs)
Spotlight on Criminal Justice: National Criminal Justice Month – March
The United States is at a Tipping Point on Juvenile Life Without Parole
Considerations for Florida’s 2023 Privacy Journey